Fairview faced a class-action complaint filed on behalf of plaintiff Samuel Zean who purchased a medical device from the organization that required “periodic purchase of replacement supplies,” according to the report.
Mr. Zean claimed he received about 25 automated telemarketing calls from Fairview regarding reordering supplies from September 2014 to August 2015 before he asked an employee to stop calling. The lawsuit alleges these calls violated the federal Telephone Consumer Protection Act, as he did not express consent to receive them.
A lower court dismissed the lawsuit, saying two largely redacted exhibits proved Mr. Zean gave prior consent for Fairview to call his phone. Mr. Zean appealed the decision, challenging the authenticity of the redacted exhibits and arguing the court should not have relied on them to make its decision, reports Bloomberg BNA.
Judge James Loken affirmed the lower court’s decision. Since Mr. Zean failed to challenge the authenticity of the redacted exhibits in the lower court, the judge said authenticity of the document at the appellate level “is a bogus issue,” according to the report.
More articles on supply chain:
HHS estimate: Mylan overcharged Medicaid by $1.27B for EpiPens
10 most-read supply chain stories in May
Fixed-dose drug combo most cost effective treatment for hypertension, study finds
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
